(EN) The present invention relates to solid state forms of a p-toluenesulfonic acid salt (PTSA) of the selective PI3K delta inhibitor (S)-2-(l-(4-amino-3-(3-fluor"o-4-isopropoxyphenyl)-lH-pyrazoloIS^-djpyrimidin-l-yOethyO-S-CS-fluorophenyO^H-chromen^-one (TGR-1202). The present invention also relates to methods of preparing the same, pharmaceutical compositions containing them, and methods of treating a PI3K kinase mediated disease or disorder, such as cancer, by administering the same.